Saturday, May 30, 2015

Deals

NeuroVive Asia teams up with Sanofi

May 28, 2015 · Leave a Comment 

  NeuroVive Pharmaceutical AB (publ), the mitochondrial medicine company, announces that NeuroVive Pharmaceutical Asia group has signed a collaboration agreement with Sanofi’s local affiliate for the development and commercialization of CicloMulsion in South Korea. Under the agreement NeuroVive Asia will get an upfront payment, a conditional milestone payment and royalty on potential future sales in South Korea. CicloMulsion is being developed for the treatment of reperfusion injury in cardiovascular disease. Sanofi is one of the largest global pharmaceutical companies with a prominent position... [Read the full story]

Deal News

NeuroVive Asia teams up with Sanofi

May 28, 2015 · Leave a Comment 

  NeuroVive Pharmaceutical AB (publ), the mitochondrial medicine company, announces that NeuroVive Pharmaceutical Asia group has signed a collaboration agreement with Sanofi’s local affiliate for the development and commercialization of CicloMulsion in South Korea. Under the agreement NeuroVive Asia will get an upfront payment, a conditional milestone payment and royalty on potential future sales in South Korea. CicloMulsion is being developed for the treatment of reperfusion injury in cardiovascular disease. Sanofi is one of the largest global pharmaceutical companies with a prominent position... [Read the full story]

Legal

Semafone and Eckoh agree to settlement

March 19, 2015 · Leave a Comment 

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed to a confidential settlement of their dispute over alleged infringement and invalidity of Semafone’s UK Patent (No. GB 2,473,376), to the mutual benefit of both parties.  Under the settlement, Semafone has granted a worldwide licence to their granted patents, trademarks and patent applications covering certain dual tone multi-frequency (“DTMF”) masking methods of taking secure payments over the phone, for the benefit of Eckoh, its customers and suppliers. In consideration of the licence, Eckoh... [Read the full story]

Bio

Medifocus, Inc. Announces Option Agreement With Major Academic Medical Center

May 28, 2015 · Leave a Comment 

  COLUMBIA, MD and TORONTO, ON, May 27, 2015 (Marketwired via COMTEX) — Medifocus, Inc. (otcqx:MDFZF) (MFS), a medical systems and devices company that develops and commercializes focused heat thermotherapy systems for treatment of Benign Prostatic Hyperplasia (BPH) and breast cancer, today announced that the Company has entered into an option agreement with Duke University regarding heat-activated and tumor targeted Immunotherapy. The two parties are actively negotiating an exclusive license to the Patent Rights of a Duke invention for the development of heat-activated and tumor targeted... [Read the full story]

University Tech Transfer

Medifocus, Inc. Announces Option Agreement With Major Academic Medical Center

May 28, 2015 · Leave a Comment 

  COLUMBIA, MD and TORONTO, ON, May 27, 2015 (Marketwired via COMTEX) — Medifocus, Inc. (otcqx:MDFZF) (MFS), a medical systems and devices company that develops and commercializes focused heat thermotherapy systems for treatment of Benign Prostatic Hyperplasia (BPH) and breast cancer, today announced that the Company has entered into an option agreement with Duke University regarding heat-activated and tumor targeted Immunotherapy. The two parties are actively negotiating an exclusive license to the Patent Rights of a Duke invention for the development of heat-activated and tumor targeted... [Read the full story]

People

IP Industry: we start here

March 8, 2015 · Leave a Comment 

In 2007, we set out to change the world of intellectual property, and how innovation and ideas were exchanged among IP owners and those that desired IP. We knew there were significant headwinds with an entrenched, decades-old ecosystem of long held beliefs about the “way things ought to be done” and who were we to come along and try to change things. None of this did anything to deter us; it drove us even harder. Not to gloat or brag, but many of the world’s LARGEST IP Owners and Transactors are now our customers- more on that in later posts.  They see the same future. IP Attorneys said... [Read the full story]

Deals

NeuroVive Asia teams up with Sanofi

  NeuroVive Pharmaceutical AB (publ), the mitochondrial medicine company, announces that NeuroVive Pharmaceutical Asia group has signed a collaboration agreement with Sanofi’s local affiliate for the development and commercialization of CicloMulsion in South Korea. Under the agreement NeuroVive Asia will get an upfront payment, a conditional... Read more of this article


WiLAN Acquires Industrial Automation Technology

  OTTAWA, CANADA, May 28, 2015 (Marketwired via COMTEX) — WiLAN announced that its wholly-owned subsidiary, Automation Middleware Solutions, Inc., has acquired a portfolio of patented technology that relates to the automation of industrial facilities, including manufacturing plants and refineries. WiLAN has entered into a licensing partnership,... Read more of this article


KBR and EXELUS Sign Technology Licensing Agreement

  KBR Inc. announced today that it has signed an alliance agreement with Exelus Inc., a leading developer of green chemical technologies, to allow KBR to exclusively license Exelus’ Solid Acid Catalyst (ExSact) for KBR’s Solid Acid Alkylation Technology (K-SAAT). Global demand for motor fuels continues to rise while stricter environmental... Read more of this article


Highlands Natural acquires 75% interest in Diversion Technologies’ patents portfolio

  Highlands Natural Resources, the London listed oil and gas company, says that the agreement in respect to its all share acquisition of a 75% interest in Diversion Technologies’ current patent applications, in the US, UK, Canada and globally, has been signed. These patent applications cover a new well stimulation (fracking) diverter technology... Read more of this article


MyDx Signs Exclusive Patent Sublicense Agreement

  MyDx, Inc., (OTC PINK: MYDX), the developer of MyDx™ (My Diagnostic), the first handheld chemical analyzer for consumers, has signed an exclusive patent sublicense agreement with Next Dimension Technologies, Inc. (“NDT”), a developer of electronic nose chemical sensing technology used by NASA, and funded by the Bill & Melinda... Read more of this article


KBR secures design and license services deal from Togliattiazot

  Texas-based KBR has secured a contract to revamp OJSC Togliattiazot’s (ToAZ) seven ammonia plants in Togliatti, Samara, Russia. The company has not disclosed the financial details of the deal. Under the contract, KBR would provide licensing, basic engineering design, front-end engineering and design services to the plants. “We are... Read more of this article


Quest Solution Signs Patent License Agreement with NCR

  HENDERSON, NV / ACCESSWIRE / May 27, 2015 / Quest Solution, Inc, “The Company” (otcqb:QUES), a leading provider in the technology, software, and mobile data collection systems business, announced today that it has signed an important patent license agreement with NCR Corporation, the global leader in consumer transaction technologies.... Read more of this article


Medifocus, Inc. Announces Option Agreement With Major Academic Medical Center

  COLUMBIA, MD and TORONTO, ON, May 27, 2015 (Marketwired via COMTEX) — Medifocus, Inc. (otcqx:MDFZF) (MFS), a medical systems and devices company that develops and commercializes focused heat thermotherapy systems for treatment of Benign Prostatic Hyperplasia (BPH) and breast cancer, today announced that the Company has entered into an option... Read more of this article


Sciclone Pharma (SCLN), Theravance (TBPH) Enter VIBATIV Commercialization, Development Agreement

  Sciclone Pharma (Nasdaq: SCLN) and Theravance Biopharma, Inc. (Nasdaq: TBPH) announced they have entered into a development and commercialization agreement granting SciClone exclusive development and commercial rights for the antibiotic VIBATIV (telavancin) in China and certain adjacent territories. The companies plan to pursue development and... Read more of this article


WiLAN, GammaTech Enter Multi-Year Patent License Agreement

  WiLAN (NASDAQ: WILN) and GammaTech Computer Corporation (“GammaTech”) have signed a multi-year patent license renewal agreement. The running royalty license covers GammaTech products sold worldwide that use certain wireless technologies. The consideration to be paid by GammaTech to WiLAN and all other terms of the renewal agreement... Read more of this article


More Posts From Deals

Legal

Semafone and Eckoh agree to settlement

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed... 


Iteris, Wavetronix Settle Patent Infringement Litigation

  SANTA ANA, Calif.–Iteris, Inc. (NYSE MKT: ITI), a leader in providing... 


More Posts From Legal

University Tech Transfer

Medifocus, Inc. Announces Option Agreement With Major Academic Medical Center

  COLUMBIA, MD and TORONTO, ON, May 27, 2015 (Marketwired via COMTEX) —... 


Biomecite Diagnostics Signs Option Agreement with UM Baltimore

  BALTIMORE, May 6, 2015 /PRNewswire/ — University of Maryland (UM) Ventures... 


More Posts From University Tech Transfer